iRadimed Corporation - Common Stock (NQ:IRMD)

iRadimed (NASDAQ:IRMD) reported record third-quarter revenue as shipments of its newly launched 3870 MR IV pump accelerated, while the company said it is moderating its production ramp to protect...

What iRadimed (IRMD) Said on Its Q3 Earnings Call ↗

October 30, 2026

Via MarketBeat

Performance

52-Week Range 17.8% below 52-week high

88.67

76.3552W Low 107.9052W High

1 Week

76.351W Low 86.931W High

iRadimed Corporation - Common Stock (IRMD) traded between $76.35 and $107.90 over the past 52 weeks and last traded at $88.67, 17.8% below its 52-week high. Over the past week it ranged between $76.35 and $86.93.

Past 12 Months

+5.7%

+2.6%

-4.8%

+3.3%

-7.1%

+5.4%

1W +$4.74

1M +$2.20

3M -$4.45

6M +$2.81

YTD -$6.83

1Y +$4.56

IRMD was +5.4% over the past year, +3.3% over six months, -7.1% year to date, +5.7% in the last week.

12 Months vs Market

IRMD

+5.4%

DIA

+12.6%

SPY

+12.2%

QQQ

+9.3%

IWM

+15.7%

Over the past 12 months IRMD returned +5.4% versus DIA (Dow) +12.6%, SPY (S&P 500) +12.2%, QQQ (Nasdaq 100) +9.3% and IWM (Russell 2000) +15.7%.

Volume & Liquidity 1.19× 3-mo avg

Today 147,406 3-mo avg 123.5K

167.7K

116.9K

123.5K

129.4K

YTD

112.8K

107.8K

IRMD most recently traded 147,406 shares against a 3-month average daily volume of 123.5K.

More News

IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

October 30, 2026

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

October 23, 2026

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

IRADIMED (NASDAQ:IRMD) Beats Q2 EPS, Reaffirms Full-Year Guidance ↗

July 31, 2026

Via Chartmill

IRADIMED (NASDAQ:IRMD) Beats Q1 Estimates, But Cautious Q2 Guidance Tempers Outlook ↗

May 01, 2026

Via Chartmill

IRADIMED CORP (NASDAQ:IRMD) Beats Q4 2025 Estimates and Raises Dividend ↗

February 10, 2026

Via Chartmill

September 23, 2026

IRadimed (IRMD) Q2 2026 Earnings Call Transcript ↗

August 07, 2026

iRadimed Q2 Earnings Call Highlights ↗

July 31, 2026

Via MarketBeat

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

July 31, 2026

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

July 24, 2026

IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It ↗

June 02, 2026

Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? ↗

May 25, 2026

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

May 20, 2026

Why Iradimed Stock Topped the Market Today ↗

May 01, 2026

IRADIMED CORPORATION Reports First Quarter 2026 Financial Results

May 01, 2026

Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. ↗

April 28, 2026

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

April 27, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

April 10, 2026

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

March 16, 2026

IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter ↗

February 17, 2026

Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake ↗

February 17, 2026

Why Iradimed Stock Soared Today ↗

February 10, 2026

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

February 10, 2026